Literature DB >> 33220233

Modification of Proteins by Metabolites in Immunity.

C Diskin1, T A J Ryan1, L A J O'Neill2.   

Abstract

Immunometabolism has emerged as a key focus for immunologists, with metabolic change in immune cells becoming as important a determinant for specific immune effector responses as discrete signaling pathways. A key output for these changes involves post-translational modification (PTM) of proteins by metabolites. Products of glycolysis and Krebs cycle pathways can mediate these events, as can lipids, amino acids, and polyamines. A rich and diverse set of PTMs in macrophages and T cells has been uncovered, altering phenotype and modulating immunity and inflammation in different contexts. We review the recent findings in this area and speculate whether they could be of use in the effort to develop therapeutics for immune-related diseases.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Year:  2020        PMID: 33220233     DOI: 10.1016/j.immuni.2020.09.014

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  20 in total

1.  Enhanced T Cell Glucose Uptake Is Associated With Progression of Beta-Cell Function in Type 1 Diabetes.

Authors:  Rong Tang; Ting Zhong; Li Fan; Yuting Xie; Juan Li; Xia Li
Journal:  Front Immunol       Date:  2022-05-23       Impact factor: 8.786

Review 2.  Post-Translational Modifications of STING: A Potential Therapeutic Target.

Authors:  Jiaqi Kang; Jie Wu; Qinjie Liu; Xiuwen Wu; Yun Zhao; Jianan Ren
Journal:  Front Immunol       Date:  2022-05-06       Impact factor: 8.786

3.  MEF2C promotes M1 macrophage polarization and Th1 responses.

Authors:  Xibao Zhao; Qianqian Di; Han Liu; Jiazheng Quan; Jing Ling; Zizhao Zhao; Yue Xiao; Han Wu; Zherui Wu; Wengang Song; Huazhang An; Weilin Chen
Journal:  Cell Mol Immunol       Date:  2022-02-22       Impact factor: 22.096

Review 4.  The Emerging Application of Itaconate: Promising Molecular Targets and Therapeutic Opportunities.

Authors:  Jiaqi Lin; Jinxuan Ren; Dave Schwinn Gao; Yi Dai; Lina Yu
Journal:  Front Chem       Date:  2021-05-12       Impact factor: 5.221

5.  Metabolic modeling of single Th17 cells reveals regulators of autoimmunity.

Authors:  Allon Wagner; Chao Wang; Johannes Fessler; David DeTomaso; Julian Avila-Pacheco; James Kaminski; Sarah Zaghouani; Elena Christian; Pratiksha Thakore; Brandon Schellhaass; Elliot Akama-Garren; Kerry Pierce; Vasundhara Singh; Noga Ron-Harel; Vivian Paraskevi Douglas; Lloyd Bod; Alexandra Schnell; Daniel Puleston; Raymond A Sobel; Marcia Haigis; Erika L Pearce; Manoocher Soleimani; Clary Clish; Aviv Regev; Vijay K Kuchroo; Nir Yosef
Journal:  Cell       Date:  2021-07-02       Impact factor: 66.850

Review 6.  Lactylation: a Passing Fad or the Future of Posttranslational Modification.

Authors:  Qi Xin; Hai Wang; Qinglin Li; Sinan Liu; Kai Qu; Chang Liu; Jingyao Zhang
Journal:  Inflammation       Date:  2022-02-27       Impact factor: 4.657

7.  4-Octyl-Itaconate and Dimethyl Fumarate Inhibit COX2 Expression and Prostaglandin Production in Macrophages.

Authors:  Ciana Diskin; Alessia Zotta; Sarah E Corcoran; Victoria J Tyrrell; Zbigniew Zaslona; Valerie B O'Donnell; Luke A J O'Neill
Journal:  J Immunol       Date:  2021-10-11       Impact factor: 5.426

Review 8.  Regulation of Transcription Factor NF-κB in Its Natural Habitat: The Nucleus.

Authors:  Susanne Bacher; Johanna Meier-Soelch; Michael Kracht; M Lienhard Schmitz
Journal:  Cells       Date:  2021-03-29       Impact factor: 6.600

9.  Lactate and IL6 define separable paths of inflammatory metabolic adaptation.

Authors:  Stefanie Dichtl; Laura Lindenthal; Leonie Zeitler; Kristina Behnke; Daniela Schlösser; Birgit Strobl; Jürgen Scheller; Karim C El Kasmi; Peter J Murray
Journal:  Sci Adv       Date:  2021-06-23       Impact factor: 14.136

10.  Production of an Animal Model of Semi-Yin and Semi-Yang Syndrome with Diabetic Ulcers and Study of Its Pathological and Metabolic Features.

Authors:  Yu Liu; Jian-Ping Shi; Wu Xiong; Yang Liu; Yu Yan; Chao-Qi Yin; Yu-Qi Jiao; Xi Zhang; Jian-Da Zhou
Journal:  Evid Based Complement Alternat Med       Date:  2021-06-26       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.